Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00592774 · ClinicalTrials.gov registry record · Phase 2
Dose-Tolerability Titration Study to Evaluate The Efficacy And Safety Of Perampanel (E2007) In Patients With Post-Herpetic Neuralgia (PHN)
A Phase 2 study of Neuralgia, sponsored by Eisai.
- Completed
- Registry status
- Phase 2
- Development phase
- 146
- Enrollment target
- 20
- Study locations
NCT00592774: Completed Phase 2 study of Neuralgia, sponsored by Eisai.
NCT00592774 is a Phase 2 study of Neuralgia that has completed, run by Eisai. The registered enrollment target is 146 participants, above the 69-participant average among 5 other Neuralgia trials with a reported enrollment target (112% higher). The trial reports 20 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00592774, a Phase 2 study of Neuralgia, has completed, sponsored by Eisai.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 146 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of the study is to determine the efficacy and safety of Perampanel (E2007) in patients with Post-Herpetic Neuralgia (PHN).
Primary Outcome
Average pain scores are based on pain intensity (11-point Likert-type numerical scale, where 0=no pain and 10=worst possible pain), reported by the subjects in a daily diary. The average pain score for baseline was calculated using the average of the last 7 scores prior to randomization, and the average pain score for Week 15 was computed using the average of the last 7 on-treatment scores prior to Week 15, and they were reported by treatment group.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG E2007 (perampanel)
Study Locations (20)
Florida
- - Boca Raton
- - Bradenton
- - Daytona Beach
- - Delray Beach
- - Fort Lauderdale
- - Fort Myers
- - Kissimmee
- - Largo
- - Miami
- - Naples
California
- - Los Angeles
- - Sacramento
- - San Diego
- - San Francisco
Arizona
- - Peoria
- - Tucson
Colorado
- - Boulder
- - Denver
Arkansas
- - Little Rock
Connecticut
- - Milford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 146 participants |
| Start Date | 2008-01 |
| Est. Completion | 2009-03 |
| Phase | Phase 2 |
What the finished NCT00592774 record still lists
NCT00592774 is an interventional study that assigns participants to a tested intervention. The registered 146 participants enrollment target is mid-sized for trials with a published cap, above the 69-participant average among 5 other Neuralgia trials with a reported enrollment target (112% higher).
The record links to 1 condition, with Neuralgia appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT00592774 names 20 study sites across 6 states, led by Florida, California, Arizona.
Frequently Asked Questions
What is clinical trial NCT00592774 about?
NCT00592774 is a clinical study titled "Dose-Tolerability Titration Study to Evaluate The Efficacy And Safety Of Perampanel (E2007) In Patients With Post-Herpetic Neuralgia (PHN)". The purpose of the study is to determine the efficacy and safety of Perampanel (E2007) in patients with Post-Herpetic Neuralgia (PHN).
What is the current status of trial NCT00592774?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 146 participants. The study started on 2008-01. Estimated completion is 2009-03.
What conditions does trial NCT00592774 study?
This clinical trial studies the following conditions: Neuralgia.
What interventions are being tested in trial NCT00592774?
The interventions under investigation include: Placebo (DRUG), E2007 (perampanel) (DRUG).
Who is sponsoring clinical trial NCT00592774?
This trial is sponsored by Eisai, which has 287 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00592774 being conducted?
This trial has 20 study locations across Arizona, Arkansas, California, Colorado, Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neuralgia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Virtual Reality (VR) Self-Hypnosis Software
RECRUITING · NA
-
MRI-Guided Cryoablation to Alleviate Pain in Head, Neck and Spine
RECRUITING
-
Safety and Effectiveness of Magnetic Peripheral Nerve Stimulation for the Treatment of Chemotherapy Induced Neuropathy
COMPLETED
-
A 17-Week Trial To Assess Pregabalin For The Treatment Of Nerve Pain Due To Spinal Cord Injury
COMPLETED · Phase 3
-
GET Living: Graded Exposure Treatment for Children and Adolescents With Chronic Pain
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03490929 · 146 participants · Phase 4
CEUS for Blunt Abdominal Trauma in Children
- NCT04755062 · 146 participants · NA
A Culturally-relevant Micronutrient-dense Plant-rich (mNDPR) Dietary Intervention for Native Americans
- NCT04867954 · 146 participants
Development of 4D Flow MRI for Risk Stratification of Variceal Bleeding in Cirrhosis
- NCT05051618 · 146 participants · NA
Exercise Training for Managing Major Depressive Disorder in Multiple Sclerosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia